Cytosorbents Corporation ( CTSO) - Stock Earnings
CTSO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.5 million USD | 9.2 million USD |
| 2026Q1 | -5.1 million USD | 8.9 million USD |
| 2026Q2 | -4.4 million USD | 9.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CTSO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.2 million USD | 31.1 million USD |
| 2024 | -20.7 million USD | 35.6 million USD |
| 2025 | -8.2 million USD | 37.1 million USD |
| 2026 Est. | — | — |
CTSO
Price: $3.79
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.29 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 305200
Ebitda: -2.1 millionMarket Capitalization: 12.2 million